Cargando…
2% Ganciclovir Eye Drops Control Posner-Schlossman Syndrome Relapses With/Without Cytomegalovirus Intraocular Reactivation
BACKGROUND: To observe and compare the efficacy of 2% ganciclovir eye drops in the treatment of Posner-Schlossman Syndrome relapses with/without cytomegalovirus intraocular reactivation. METHODS: A prospective cohort study enrolling 101 patients diagnosed unilateral Posner-Schlossman Syndrome in Eye...
Autores principales: | Sheng, Qilian, Zhai, Ruyi, Fan, Xintong, Kong, Xiangmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959537/ https://www.ncbi.nlm.nih.gov/pubmed/35355609 http://dx.doi.org/10.3389/fmed.2022.848820 |
Ejemplares similares
-
The Analysis of Dynamic Changes and Prognosis of Posner–Schlossman Syndrome with Cytomegalovirus Infection and Antiviral Therapy
por: Sheng, Qilian, et al.
Publicado: (2021) -
Polymorphisms of the cytomegalovirus glycoprotein B genotype in patients with Posner-Schlossman syndrome
por: Zhai, Ruyi, et al.
Publicado: (2022) -
Posner-Schlossman syndrome relapse following inactivated COVID-19 vaccination in China
por: Sheng, Qilian, et al.
Publicado: (2023) -
Posner-Schlossman Syndrome
por: Lippert, Jason, et al.
Publicado: (2020) -
Aqueous Cytokine Changes Associated with Posner-Schlossman Syndrome with and without Human Cytomegalovirus
por: Li, Jing, et al.
Publicado: (2012)